<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-11-07</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-11-07</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>74</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>5</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ“° å…¬ä¼—å·</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
"åŸºå› æ˜¾å¾®é•œ"NanoSeqæŠ€æœ¯çµæ•åº¦æå‡ç™¾å€ï¼Œé¦–æ¬¡ç»˜åˆ¶å¥åº·äººç™Œç—‡çªå˜å…¨æ™¯å›¾ï¼›Perturb-seqæŠ€æœ¯åœ¨ä½“åº”ç”¨é¦–ç§€ï¼Œå¼•é¢†å•ç»†èƒ2.0æ—¶ä»£ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è‚ é“èŒç¾¤ä»£è°¢ç‰©ä¸è‚¿ç˜¤å…ç–«è°ƒæ§æœºåˆ¶ï¼ˆè¿åŠ¨ã€è›‹ç™½ã€ä»£è°¢ç‰©ç­‰è§’åº¦ï¼‰ã€‚<br />
- éå°ç»†èƒè‚ºç™Œï¼ˆNSCLCï¼‰çš„å•ç»†èƒã€ç©ºé—´è½¬å½•ç»„å­¦åŠé£é™©åˆ†å±‚ã€‚<br />
- è‚¿ç˜¤å…ç–«ç ”ç©¶æ–°çƒ­ç‚¹ï¼ˆå¼•æµæ·‹å·´ç»“ã€CD8 Tç»†èƒåŠŸèƒ½ï¼‰ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- æ–°ä¸€ä»£çº³ç±³æµ‹åºï¼ˆNanoSeqï¼‰å®ç°å¤šå…‹éš†æ ·æœ¬ä½“ç»†èƒçªå˜çš„æ— åå€šæ£€æµ‹ã€‚<br />
- æé™Metaåˆ†æï¼ˆLimit meta-analysisï¼‰æä¾›å°æ ·æœ¬æˆ–æ½œåœ¨åå€šä¸‹çš„ç¨³å¥æ•ˆåº”ä¼°è®¡ã€‚</p>
<h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
- <strong>GSE308237/GSE307892/GSE307740/GSE298534/GSE298465</strong>ï¼šé€šè¿‡æ–°å‹CHANGE-seq-BEæŠ€æœ¯ï¼Œå®ç°å¯¹Casä¾èµ–æ€§ç¢±åŸºç¼–è¾‘å™¨åŸºå› ç»„è„±é¶æ´»æ€§çš„çµæ•ä¸”æ— åå€šçš„ä½“å¤–é«˜é€šé‡åˆ†æï¼Œä¸ºåŸºå› ç¼–è¾‘çš„å®‰å…¨æ€§è¯„ä¼°å¸¦æ¥çªç ´ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- <strong>å…ç–«ä¸ç‚ç—‡</strong>ï¼šGSE294668ç ”ç©¶äº†è¿‘çº¢å¤–å…‰ç”Ÿç‰©è°ƒèŠ‚ï¼ˆPBMï¼‰åœ¨å°é¼ è¿‡æ•æ€§å“®å–˜æ¨¡å‹ä¸­ï¼Œé€šè¿‡è°ƒæ§Th2ç»†èƒå› å­å’Œç‚ç—‡ç»†èƒæµ¸æ¶¦çš„æ²»ç–—æ½œåŠ›ã€‚<br />
- <strong>åŸºå› è°ƒæ§ä¸ç–¾ç—…</strong>ï¼šGSE270168/GSE270169æ­ç¤ºäº†GAPDHåœ¨æ€¥æ€§é«“ç³»ç™½è¡€ç—…ï¼ˆAMLï¼‰ä¸­è°ƒæ§è½¬å½•ç¨³å®šæ€§ã€è›‹ç™½ç¿»è¯‘åŠç»†èƒå¢æ®–çš„å…³é”®ä½œç”¨ã€‚<br />
- <strong>åŸºå› ç¼–è¾‘æŠ€æœ¯</strong>ï¼šGSE308237ç­‰ç³»åˆ—ç ”ç©¶å±•ç¤ºäº†CHANGE-seq-BEåœ¨è¯„ä¼°åŸºå› ç¼–è¾‘å·¥å…·ï¼ˆå¦‚Cas9å’Œç¢±åŸºç¼–è¾‘å™¨ï¼‰è„±é¶æ•ˆåº”æ–¹é¢çš„åˆ›æ–°åº”ç”¨ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- <strong>CHANGE-seq-BE</strong>ï¼šä¸€ç§æ–°å‹é«˜é€šé‡æŠ€æœ¯ï¼Œç”¨äºåŒæ—¶ã€çµæ•ä¸”æ— åå€šåœ°åˆ†æåŸºå› ç¼–è¾‘å·¥å…·çš„åŸºå› ç»„è„±é¶æ´»æ€§ã€‚<br />
- <strong>PRO-seq/mRNA-seq</strong>ï¼šç”¨äºè§£æçŠ¬ç±»å¯åŠ¨å­å’Œå¢å¼ºå­çš„è½¬å½•ç»“æ„ï¼Œä»¥åŠå¿«é€Ÿæ¿€æ´»çƒ­ä¼‘å…‹ååº”ã€‚</p>
<h3>ğŸ”¬ æœŸåˆŠæ–‡ç« </h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
å¼€å‘äº†é›†æˆä¸´åºŠå’ŒåŸºå› ç»„æ•°æ®çš„é«“æ¯ç»†èƒç˜¤èŸèƒåˆ†æé—¨æˆ·ï¼Œæ”¯æŒå¯¹æ‚£è€…äºšç»„å’Œç”Ÿå­˜ç»“æœçš„æ·±å…¥åˆ†æã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- çº³ç±³é¢—ç²’æŠ€æœ¯ä¼˜åŒ–CAR-Tç»†èƒå…ç–«æ²»ç–—ç­–ç•¥ï¼Œå…‹æœå®ä½“ç˜¤æŒ‘æˆ˜ã€‚<br />
- æ¢ç´¢åˆ†å­è¡¨å¾åœ¨å±€é™æ€§å°¤æ–‡è‚‰ç˜¤é¢„åè¯„ä¼°ä¸­çš„ä½œç”¨ã€‚<br />
- æ•´åˆå¤šé¡¹ä¸´åºŠè¯•éªŒæ•°æ®ï¼Œæ„å»ºé«“æ¯ç»†èƒç˜¤æ‚£è€…çš„ä¸´åºŠåŸºå› ç»„åˆ†æå¹³å°ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- é¦–æ¬¡æ„å»ºé«“æ¯ç»†èƒç˜¤èŸèƒåˆ†æé—¨æˆ·ï¼Œå®ç°ä¸´åºŠä¸åŸºå› ç»„æ•°æ®çš„ç»¼åˆæ¢ç´¢ã€‚<br />
- åˆ©ç”¨çº³ç±³é¢—ç²’å®ç°CAR-Tç»†èƒçš„ç²¾ç¡®é€’é€å’Œå…ç–«è°ƒèŠ‚ã€‚</p>
<h3>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
æœ¬æ¬¡ç¤¾åŒºä¼šè®®èšç„¦äºâ€œGraceful Internet Packagesâ€ï¼Œæ—¨åœ¨æ¢è®¨å¦‚ä½•ä¼˜åŒ–äº’è”ç½‘æ•°æ®ä¼ è¾“æ•ˆç‡ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- äº’è”ç½‘æ•°æ®åŒ…çš„ä¼˜é›…ä¼ è¾“æœºåˆ¶<br />
- ç¤¾åŒºåä½œåœ¨ç½‘ç»œæŠ€æœ¯å‘å±•ä¸­çš„ä½œç”¨</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- ï¼ˆæ–‡ç« æ‘˜è¦ä¿¡æ¯ä¸è¶³ï¼Œæ— æ³•æç‚¼å…·ä½“æŠ€æœ¯äº®ç‚¹ï¼‰</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
DirectRMæŠ€æœ¯é¦–æ¬¡å®ç°å¯¹è½¬å½•æœ¬å’Œåˆ†å­å†…å¤šé‡RNAä¿®é¥°ç›¸äº’ä½œç”¨çš„æ•´åˆæ£€æµ‹ï¼Œæ­ç¤ºRNAä¿®é¥°çš„å¤æ‚æ€§ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¢ç´¢å¤šé‡RNAä¿®é¥°åœ¨è½¬å½•æœ¬å’Œåˆ†å­å†…çš„ç›¸äº’ä½œç”¨ã€‚<br />
- æ­ç¤ºåº”æ¿€æ¿€ç´ å¦‚ä½•é€šè¿‡æŸ“è‰²è´¨ç»“åˆçš„lncRNAæ‹›å‹ŸPRC2ï¼Œæ²‰é»˜å…³é”®è„‘åŸºå› ï¼Œå»ºç«‹åº”æ¿€ä¿¡å·ä¸ç¥ç»å…ƒåŸºå› è¡¨è¾¾æ”¹å˜çš„è¡¨è§‚é—ä¼ é€šè·¯ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- DirectRMï¼šæ•´åˆæ€§ç›´æ¥RNAæµ‹åºæŠ€æœ¯ï¼Œç”¨äºæ£€æµ‹æ™¯è§‚å’Œå¤šé‡RNAä¿®é¥°é—´çš„ä¸²æ‰°ã€‚<br />
- RNAæµ‹åºï¼šç”¨äºæ­ç¤ºåº”æ¿€æ¿€ç´ æ²‰é»˜åŸºå› çš„æœºåˆ¶ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“° å…¬ä¼—å· (23æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>ç ”ç©¶è‚ é“èŒç¾¤ä»£è°¢ç‰©ä¸è‚¿ç˜¤å…ç–«ï¼Œè¿™ç¯‡æ–‡ç« å‡­ä»€ä¹ˆå‘åœ¨Immunityä¸Šï¼Ÿ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå°å¼ èŠç§‘ç ”<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€immunityã€ä»£è°¢<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç ”ç©¶è‚ é“èŒç¾¤ä»£è°¢ç‰©ä¸è‚¿ç˜¤å…ç–«ï¼Œè¿™ç¯‡æ–‡ç« å‡­ä»€ä¹ˆå‘åœ¨Immunityä¸Šï¼Ÿ<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821290&amp;idx=1&amp;sn=49fd27f887a1fc68219bdd737b041dda" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>æ–°æ€è·¯ï½œéå°ç»†èƒè‚ºç™Œçš„å•ç»†èƒå’Œç©ºé—´è½¬å½•ç»„å­¦åˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šä½œå›¾ä¸«<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€ç©ºé—´è½¬å½•ç»„ã€ç©ºé—´ç»„å­¦ã€è½¬å½•ç»„<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šæœ€è¿‘æœ‰å°ä¼™ä¼´åæ˜ æ”¶ä¸åˆ°æ¨é€ï¼Œå› ä¸ºå…¬ä¼—å·æ”¹äº†æ¨é€ç®—æ³•ï¼Œç°åœ¨éœ€è¦åŠ æ˜Ÿæ ‡ï¼Œå¤šç‚¹èµã€ç‚¹åœ¨çœ‹ï¼Œæ‰èƒ½å‡†æ—¶æ”¶åˆ°æ¨é€å“¦ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2NTE1MzU4NQ==&amp;mid=2247523366&amp;idx=1&amp;sn=d10e332a7d7b0c7097793ad8b04ac45f" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>æœ€æ–°8.1åˆ†éè‚¿ç˜¤ç”Ÿä¿¡ï¼Œé’ˆå¯¹PANoptosisçƒ­ç‚¹è¿›è¡Œæœºå™¨å­¦ä¹ +å•ç»†èƒç­›é€‰+ç®€å•éªŒè¯ï¼Œå…¨æ–‡åªæœ‰4ä¸ªFigureï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šä¸œæ™“ç”Ÿç‰©<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å•ç»†èƒã€ç”Ÿä¿¡<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&amp;mid=2247492984&amp;idx=1&amp;sn=afa1eeb1fd88acee0e552c4081f945e9" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>æœ€æ–°8.5åˆ†å•åŸºå› ç”Ÿä¿¡ï¼Œæ³›ç™Œ+å•ç»†èƒ+ç©ºè½¬+éªŒè¯ï¼Œå¤šç»„å­¦åˆ†æä¸€èµ·ä¸Šåˆ†ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€åŸºå› ç»„ã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503864&amp;idx=1&amp;sn=027be6a51460a6f4dcfd2d69a5d6d8bf" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>è¿™ç¯‡Cellä¸»åˆŠå…³æ³¨â€œè¿åŠ¨-è‚ é“èŒç¾¤-ä»£è°¢ç‰©-æŠ—è‚¿ç˜¤å…ç–«â€ï¼Œæ€è·¯æ¸…æ™°ï¼Œè¯æ®æ‰å®ï¼Œé€»è¾‘å¤ªä¸¥è°¨äº†ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå°å¼ èŠç§‘ç ”<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€ä»£è°¢<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šè¿™ç¯‡æœ€æ–°çš„Cellä¸»åˆŠå…³æ³¨â€œè¿åŠ¨-è‚ é“èŒç¾¤-ä»£è°¢ç‰©-æŠ—è‚¿ç˜¤å…ç–«â€ï¼Œæ€è·¯æ¸…æ™°ï¼Œè¯æ®æ‰å®ï¼Œé€»è¾‘å¤ªä¸¥è°¨äº†ï¼<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821290&amp;idx=2&amp;sn=b68081d189d024cb27ad2a2b6c771789" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>å›½è‡ªç„¶å…³æ³¨è‚¿ç˜¤å…ç–«ï¼Œè¿™ç¯‡Immunityä¸Šçš„æ–‡ç« å¯ä»¥æä¾›ä¸€ä¸ªæ–°è§’åº¦â€¦â€¦</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå°å¼ èŠç§‘ç ”<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€immunity<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šåŒæ ·æ˜¯åšè‚¿ç˜¤å…ç–«ï¼Œè¿™é¡¹ç ”ç©¶å‡­ä»€ä¹ˆå‘åœ¨Cellå­åˆŠImmunityä¸Šï¼Ÿå¦‚æœæ”¹æˆå›½è‡ªç„¶é¡¹ç›®ï¼Œä½ è§‰æ˜¯æ˜¯å¦åˆé€‚ï¼Ÿ<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821291&amp;idx=3&amp;sn=a1b57f89856d33170d92225f34fc3a05" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>è‚¿ç˜¤å…ç–«æ–°è§’åº¦ï¼šå¼•æµæ·‹å·´ç»“ä¸ºä½•æˆä¸ºç ”ç©¶çƒ­ç‚¹ï¼Ÿ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå°å¼ èŠç§‘ç ”<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šè‚¿ç˜¤å…ç–«æ–°è§’åº¦ï¼šå¼•æµæ·‹å·´ç»“ä¸ºä½•æˆä¸ºç ”ç©¶çƒ­ç‚¹ï¼Ÿ<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821291&amp;idx=1&amp;sn=e1767b662c7fe6fa971aad19dd2ca9b8" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>å¼ è€€é˜³å›¢é˜Ÿæ­ç¤ºTRIM28ä»‹å¯¼çš„SUMOåŒ–ä¿®é¥°è°ƒæ§åº”æ¿€é¢—ç²’åŠ¨æ€æ€§çš„æ–°æœºåˆ¶ | Cell Presså¯¹è¯ç§‘å­¦å®¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šCellPresså…¨ç§‘å­¦<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€TME<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šè¯¥ç ”ç©¶å·¥ä½œä¸ºè§£ææ¶²â€“æ¶²ç›¸åˆ†ç¦»ç›¸å…³ç”Ÿç‰©è¿‡ç¨‹æä¾›äº†æ–°çš„å·¥å…·ä¸æ€è·¯ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247657180&amp;idx=1&amp;sn=e7a4ab9b1dfe988863f202f4a30e9281" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>Nature medicineåŒæ¬¾ | è«å…°è¿ªé…è‰²</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šåœ¨ç”Ÿä¿¡çš„å‘é‡ŒæŒ–å‘€æŒ–å‘€æŒ–<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTME<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šè«å…°è¿ªé…è‰²ï¼Œå’Œç§‘ç ”ä¹Ÿæ²¾è¾¹å„¿çš„ï¼<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkwODUyOTYzMw==&amp;mid=2247488593&amp;idx=1&amp;sn=cfa94ae01fc48e60b3e31cba3247a1eb" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>åŠŸèƒ½å¤±è°ƒçš„CD8 Tç»†èƒè½´çš„æŒç»­è¡¥å……ä¸æ™šæœŸä¹³è…ºç™ŒåŒ–å­¦å…ç–«æ²»ç–—çš„ååº”ç›¸å…³</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒå¤©åœ°<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šé€šè¿‡æ•´åˆscRNA-seqä¸scTCR-seqæ•°æ®ï¼Œé«˜åˆ†è¾¨ç‡è§£æäº†åŒ–å­¦å…ç–«æ²»ç–—åœ¨è½¬ç§»æ€§ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­å¼•å‘çš„Tç»†èƒå…ç–«å›¾è°±é‡å¡‘ï¼Œæ­ç¤ºäº†ä»å…‹éš†å¢æ®–åˆ°è°±ç³»åˆ†åŒ–çš„åŠ¨æ€åº”ç­”è¿‡ç¨‹ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247533526&amp;idx=1&amp;sn=bc403b317bd1a3ed3dd939e3f218d95a" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 13 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-å…¬ä¼—å·">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (44æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE294668 è„‰å†²å¼ 980 nm è¿‘çº¢å¤–å…‰ç”Ÿç‰©è°ƒèŠ‚é€šè¿‡è°ƒèŠ‚ Th2 ç»†èƒå› å­ååº”å’Œç‚ç—‡ç»†èƒæµ¸æ¶¦æ¥å‡è½» OVA è¯±å¯¼çš„è¿‡æ•æ€§å“®å–˜</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€leukemiaã€immuneã€immunityã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€resistanceã€TCGAã€DepMapã€depmapã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€methylationã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zhengyi Wu ; Shih-Chin ChengSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPhotobiomodulation (PBM) is a non-invasive therapeutic strategy that uses specific light wavelengths to stimulate cellular processes that promote tissue repair, reduce inflammation, and alleviate pain. In this study, we evaluated the efficacy of a high-intensity 980 nm near-infrared (NIR) pulsed laser in a murine model of ovalbumin (OVA)-induced allergic asthma. In OVA-sensitized mice, typical allergic features were noted, including airway wall thickening, significant peribronchial and perivascular inflammatory cell infiltration, and compressed alveolar spaces. NIR PBM treatment markedly attenuated these histological changes. At the molecular level, PBM significantly downregulated type 2 cytokine gene expression, including IL-4, IL-5 and IL-13, in the lung tissue. Flow cytometry analyses further revealed that PBM reduced the infiltration of pulmonary eosinophils and inflammatory monocytes. Transcriptomic profiling coupled with gene set enrichment analysis (GSEA) indicated that PBM suppressed NF-ÎºB-mediated inflammatory signaling while modulating Th2-related responses. Collectively, our findings demonstrate that high-intensity 980 nm NIR PBM effectively mitigates key features of allergic asthma in a murine model, supporting its potential as a non-pharmacological, non-invasive adjunct therapy for asthma management.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294668" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE274105 å®¶çŠ¬å¯åŠ¨å­å’Œå¢å¼ºå­çš„è½¬å½•ç»“æ„ä»¥åŠçƒ­ä¼‘å…‹ååº”çš„å¿«é€Ÿé‡Šæ”¾ [PRO-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€leukemiaã€TMEã€cardiacã€gliomaã€kinaseã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€Seuratã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Samu V Himanen ; Anniina VihervaaraSeries Type : OtherOrganism : Canis lupus familiarisDogs exhibit high genetic diversity due to extensive breeding, and provide a versatile model for genetics, evolution, and complex traits. While RNA synthesis and transcriptional architecture of promoters and enhancers have been extensively analyzed in human, mouse, and fly, little is known about the mechanisms that coordinate gene and enhancer transcription in dog. Here, we combine precision run-on sequencing (PRO-seq) and strand-specific mRNA-seq (mRNA-seq) to measure nascent transcription, mRNA expression and mRNA stability in golden retriever macrophage (DH82) cells. Tracking transcription at nucleotide-resolution uncovers the precise transcription start nucleotides (TSN) genome-wide, identifies the exact locations of promoters and transcribed enhancers, and quantifies transcription machineries at initiation, promoter proximal pause, gene bodies, and termination windows. Moreover, we trigger an instant transcriptional reprogramming using heat shock, and track at nucleotide-resolution, how dog cells coordinate RNA synthesis and mRNA expression across the genome. Taken together, this study describes the transcriptional landscape at nucleotide-resolution, measures RNA synthesis, mRNA expression and mRNA-stability, and identifies mechanisms of gene and enhancer reprogramming in Canis lupus familiaris.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274105" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE274106 å®¶çŠ¬å¯åŠ¨å­å’Œå¢å¼ºå­çš„è½¬å½•ç»“æ„ä»¥åŠçƒ­ä¼‘å…‹ååº”çš„å¿«é€Ÿé‡Šæ”¾ [mRNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€leukemiaã€TMEã€cardiacã€gliomaã€kinaseã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€Seuratã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Samu V Himanen ; Anniina VihervaaraSeries Type : Expression profiling by high throughput sequencingOrganism : Canis lupus familiarisDogs exhibit high genetic diversity due to extensive breeding, and provide a versatile model for genetics, evolution, and complex traits. While RNA synthesis and transcriptional architecture of promoters and enhancers have been extensively analyzed in human, mouse, and fly, little is known about the mechanisms that coordinate gene and enhancer transcription in dog. Here, we combine precision run-on sequencing (PRO-seq) and strand-specific mRNA-seq (mRNA-seq) to measure nascent transcription, mRNA expression and mRNA stability in golden retriever macrophage (DH82) cells. Tracking transcription at nucleotide-resolution uncovers the precise transcription start nucleotides (TSN) genome-wide, identifies the exact locations of promoters and transcribed enhancers, and quantifies transcription machineries at initiation, promoter proximal pause, gene bodies, and termination windows. Moreover, we trigger an instant transcriptional reprogramming using heat shock, and track at nucleotide-resolution, how dog cells coordinate RNA synthesis and mRNA expression across the genome. Taken together, this study describes the transcriptional landscape at nucleotide-resolution, measures RNA synthesis, mRNA expression and mRNA-stability, and identifies mechanisms of gene and enhancer reprogramming in Canis lupus familiaris.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274106" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE270168 GAPDH æ§åˆ¶è½¬å½•ç¨³å®šæ€§ã€è›‹ç™½è´¨ç¿»è¯‘å¹¶é©±åŠ¨æ€¥æ€§é«“ç³»ç™½è¡€ç—…ç»†èƒå¢æ®– [CLIP-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€leukemiaã€TMEã€cardiacã€gliomaã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€Scanpyã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : OtherOrganism : Homo sapiensDysregulation of RNA binding proteins (RBPs) is a hallmark in cancerous cells.In acute myeloid leukemia (AML) RBPs are key regulators of tumor proliferation. While classical RBPs have defined RNA binding domains, RNA recognition and function in AML by non-canonical RBPs (ncRBPs) remains unclear. Given the inherent complexity of targeting AML broadly, our goal was to uncover potential ncRBP candidates critical for AML survival using a CRISPR/Cas-based screening. We identified the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a pro-proliferative factor in AML cells. Based on cross-linking and immunoprecipitation (CLIP) we are defining the global targetome detecting novel RNA targets mainly located within 5â€™UTR including GAPDH, RPL13a, PKM and ENO1. The knockdown of GAPDH unveiled genetic pathways related to ribosome biogenesis, translation initiation, and regulation. Moreover, we were able to demonstrate a stabilizing effect through the GAPDH binding to target transcripts including its own mRNA, unveiling GAPDHâ€™s pivotal role in cancer. The present findings provide new insights on the pathophysiological role of GAPDH in AML.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270168" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE308237 CHANGE-seq-BE èƒ½å¤ŸåŒæ—¶å¯¹ Cas ä¾èµ–æ€§ç¢±åŸºç¼–è¾‘å™¨çš„å…¨åŸºå› ç»„è„±é¶æ´»æ€§è¿›è¡Œçµæ•ä¸”æ— åå€šçš„ä½“å¤–åˆ†æ V</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€TCGAã€sequencingã€Hi-Cã€scRNAã€scDNAã€scATACã€genomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Varun Katta ; Yichao Li ; Garret Manquen ; Shengdar TsaiSeries Type : OtherOrganism : Homo sapiensTo assess genome-wide off-target activity of base editors and Cas9 nucleases identified by CHANGE-seq-BE, Digenome-seq, and CHANGE-seq, we performed hybrid capture sequencing for five therupatic loci (B2M, CBLB, CD7, CIITA, PDCD1) in human primary T-cells and PCSK9 in human hepatocytes. We observed high on-target editing for ABE, CBE, Cas9 mRNA edited cells and potential off-targets confirmed by hybrid capture sequencing. Our results demonstrate that CHANGE-seq-BE is highly sensitive than Digenome-seq to detect more bona fide off-targets with cellular activity ranging from 0.5% to 92.2%. Moreover, ABE exhibit more off-targets than Cas9 under same delivery conditions.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308237" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE307892 CHANGE-seq-BE èƒ½å¤ŸåŒæ—¶å¯¹ Cas ä¾èµ–æ€§ç¢±åŸºç¼–è¾‘å™¨çš„å…¨åŸºå› ç»„è„±é¶æ´»æ€§è¿›è¡Œçµæ•ä¸”æ— åå€šçš„ä½“å¤–åˆ†æ IV</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€TCGAã€sequencingã€Hi-Cã€scRNAã€scDNAã€scATACã€genomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Varun Katta ; Yichao Li ; Garret Manquen ; Shengdar TsaiSeries Type : OtherOrganism : Homo sapiensTo assess genome-wide off-target activity of base editors and Cas9 nucleases identified by CHANGE-seq-BE, Digenome-seq, and CHANGE-seq, we performed hybrid capture sequencing for five therupatic loci (B2M, CBLB, CD7, CIITA, PDCD1) in human primary T-cells and PCSK9 in human hepatocytes. We observed high on-target editing for ABE, CBE, Cas9 mRNA edited cells and potential off-targets confirmed by hybrid capture sequencing. Our results demonstrate that CHANGE-seq-BE is highly sensitive than Digenome-seq to detect more bona fide off-targets with cellular activity ranging from 0.5% to 92.2%. Moreover, ABE exhibit more off-targets than Cas9 under same delivery conditions.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307892" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE307740 CHANGE-seq-BE èƒ½å¤ŸåŒæ—¶å¯¹ Cas ä¾èµ–æ€§ç¢±åŸºç¼–è¾‘å™¨çš„å…¨åŸºå› ç»„è„±é¶æ´»æ€§è¿›è¡Œçµæ•ä¸”æ— åå€šçš„ä½“å¤–åˆ†æ III</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€TCGAã€sequencingã€Hi-Cã€scRNAã€scDNAã€scATACã€genomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Cicera Lazzarotto ; Elizabeth Urbina ; GaHyun Lee ; Yichao Li ; Shengdar TsaiSeries Type : OtherOrganism : Homo sapiensTo assess CHANGE-seq-BE performance, we used it to characterize ABE8e-NRCH base editor activity targeting sickle mutation (HBBS) in the HBB gene and identified additional 29 (53% more) bona fide off-targets than CIRCLE-seq. Furthermore, CHANGE-seq-BE applied for ABE8e targeting five therapeutically relevant loci (B2M, CBLB, CD7, CIITA, and PDCD1) in human primary T-cells and compared with Digenome-seq. CHANGE-seq-BE is highly sensitive and capable of detecting bona fide off-targets while requiring approximately 20-fold less sequencing reads.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307740" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE298534 CHANGE-seq-BE èƒ½å¤ŸåŒæ—¶å¯¹ Cas ä¾èµ–æ€§ç¢±åŸºç¼–è¾‘å™¨çš„å…¨åŸºå› ç»„è„±é¶æ´»æ€§è¿›è¡Œçµæ•ä¸”æ— åå€šçš„ä½“å¤–åˆ†æ II</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€TCGAã€sequencingã€Hi-Cã€scRNAã€scDNAã€scATACã€genomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Garret Manquen ; Varun Katta ; Yichao Li ; Shengdar TsaiSeries Type : OtherOrganism : Homo sapiensTo adapt and apply for cytosone base editors (CBEs), we perfomed CHANGE-seq-BE using eA3A-BE3 to target B2M, CBLB, CD7, CIITA and PDCD1 regions at different loci. CHANGE-seq-BE identified low frequency off-target editing rates ranging from 1.7% to 7.5% that are not identified by Digenome-seq further implies CHANGE-seq-BE is highly sensitive and can identify true off-targets while requiring 20-fold fewer sequencing reads.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298534" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>GSE298465 CHANGE-seq-BE èƒ½å¤ŸåŒæ—¶å¯¹ Cas ä¾èµ–æ€§ç¢±åŸºç¼–è¾‘å™¨çš„å…¨åŸºå› ç»„è„±é¶æ´»æ€§è¿›è¡Œçµæ•ä¸”æ— åå€šçš„ä½“å¤–åˆ†æ I</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€TCGAã€sequencingã€Hi-Cã€scRNAã€scDNAã€scATACã€genomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Garret Manquen ; Varun Katta ; Yichao Li ; Shengdar TsaiSeries Type : OtherOrganism : Homo sapiensBy CHANGE-seq-BE, we identified a total of 81 potential off-targets and confirmed 95.4% frequencies of on-target editing with no evident off-targets above the detection threshold compared to controls (rhAmp-seq, IDT).<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298465" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>GSE270169 GAPDH æ§åˆ¶è½¬å½•æœ¬ç¨³å®šæ€§ã€è›‹ç™½è´¨ç¿»è¯‘å¹¶é©±åŠ¨æ€¥æ€§é«“ç³»ç™½è¡€ç—…ç»†èƒå¢æ®– [GAPDH_KD_RNAseq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€leukemiaã€TMEã€cardiacã€gliomaã€kinaseã€TCGAã€DepMapã€depmapã€RNAseqã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€transcriptomeã€proteomeã€R packageã€Scanpyã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensDysregulation of RNA binding proteins (RBPs) is a hallmark in cancerous cells.In acute myeloid leukemia (AML) RBPs are key regulators of tumor proliferation. While classical RBPs have defined RNA binding domains, RNA recognition and function in AML by non-canonical RBPs (ncRBPs) remains unclear. Given the inherent complexity of targeting AML broadly, our goal was to uncover potential ncRBP candidates critical for AML survival using a CRISPR/Cas-based screening. We identified the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a pro-proliferative factor in AML cells. Based on cross-linking and immunoprecipitation (CLIP) we are defining the global targetome detecting novel RNA targets mainly located within 5â€™UTR including GAPDH, RPL13a, PKM and ENO1. The knockdown of GAPDH unveiled genetic pathways related to ribosome biogenesis, translation initiation, and regulation. Moreover, we were able to demonstrate a stabilizing effect through the GAPDH binding to target transcripts including its own mRNA, unveiling GAPDHâ€™s pivotal role in cancer. The present findings provide new insights on the pathophysiological role of GAPDH in AML.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270169" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 34 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ”¬ æœŸåˆŠæ–‡ç«  (3æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>åŸºäºçº³ç±³é¢—ç²’çš„ CAR-T ç»†èƒå…ç–«æ²»ç–—ç­–ç•¥ï¼šæŒ‘æˆ˜ã€å½±å“å’Œå‰æ™¯</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: åµŒåˆæŠ—åŸå—ä½“ï¼ˆCARï¼‰-T ç»†èƒç–—æ³•åœ¨æ²»ç–—è¡€æ¶²ç³»ç»Ÿæ¶æ€§è‚¿ç˜¤æ–¹é¢å–å¾—äº†æ˜¾è‘—è¿›å±•ï¼Œä½†å…¶æ›´å¹¿æ³›çš„åº”ç”¨é¢ä¸´ç€åˆ¶é€ å¤æ‚æ€§ã€å®ä½“ç˜¤å¾®ç¯å¢ƒå±éšœå’Œå…ç–«æ¯’æ€§ç­‰æŒ‘æˆ˜ã€‚çº³ç±³é¢—ç²’ ï¼ˆNPï¼‰ åˆ©ç”¨å…¶ç²¾ç¡®é€’é€ã€å…ç–«è°ƒèŠ‚å’Œå¤šåŠŸèƒ½æ•´åˆèƒ½åŠ›ï¼Œä¸ºä¼˜åŒ– CAR-T ç»†èƒç–—æ³•æä¾›äº†åˆ›æ–°ç­–ç•¥ã€‚æœ¬æ–‡å…¨é¢é˜æ˜äº† CAR-T ç»†èƒæ²»ç–—çš„åŸºæœ¬æ¡†æ¶å’Œè‚¿ç˜¤å­¦åº”ç”¨ä¸­çš„æŒ‘æˆ˜ã€‚éšåï¼Œç³»ç»Ÿæ€»ç»“äº† NPs ä¸ CAR-T ç»†èƒæ²»ç–—çš„ååŒæœºåˆ¶ï¼ŒåŒ…æ‹¬ä¼˜åŒ–åŸºå› ä¿®é¥°ã€å¢å¼ºè‚¿ç˜¤éƒ¨ä½æµ¸æ¶¦ã€è°ƒèŠ‚å…ç–«æŠ‘åˆ¶è‚¿ç˜¤å¾®ç¯å¢ƒã€å‡è½»è‚¿ç˜¤æŠ—åŸå¼‚è´¨æ€§ã€å®æ—¶ç›‘æµ‹å’ŒåŠ¨æ€æ§åˆ¶ç»†èƒæ´»æ€§ã€‚æœ€ç»ˆï¼Œå®ƒå¼ºè°ƒäº†è¯¥é¢†åŸŸå†…äººå·¥æ™ºèƒ½é›†æˆçš„æ–°å…´èŒƒå¼ï¼ŒåŒæ—¶è®¨è®ºäº†è¿™ç§è”åˆæ²»ç–—æ–¹æ³•çš„ç›¸å…³æŠ€æœ¯éšœç¢å’Œæœªæ¥å‰æ™¯ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1985998009503752192/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>åˆ†å­è¡¨å¾ä¸ºå±€é™æ€§å°¤æ–‡è‚‰ç˜¤æ‚£è€…çš„é¢„åæä¾›ä¿¡æ¯ï¼šå„¿ç«¥è‚¿ç˜¤å­¦ç»„çš„æŠ¥å‘Š</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ä¸´åºŠè‚¿ç˜¤å­¦æ‚å¿—ï¼Œå°åˆ·å‰ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1985945830529081344/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>é«“æ¯ç»†èƒç˜¤èŸèƒåˆ†æé—¨æˆ·èƒ½å¤Ÿç»¼åˆæ¢ç´¢æ‚£è€…çš„ä¸´åºŠå’ŒåŸºå› ç»„æ•°æ®</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šåŸºå› ç»„<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: é«“æ¯ç»†èƒç˜¤æ˜¯ä¸€ç§æ™®éçš„ã€é«˜åº¦å¼‚è´¨æ€§çš„æ¶æ€§å°å„¿è„‘ç™Œã€‚åœ¨è¿™é¡¹ç ”ç©¶ä¸­ï¼Œæˆ‘ä»¬å¼€å‘äº†é«“æ¯ç»†èƒç˜¤èŸèƒåˆ†æé—¨æˆ·ï¼Œè¿™æ˜¯ä¸€ä¸ªåŸºäºç½‘ç»œçš„æ•°æ®åˆ†æå’Œå¯è§†åŒ–å¹³å°ï¼Œæ•´åˆäº†æ¥è‡ªä¸‰é¡¹ä¸»è¦ä¸´åºŠè¯•éªŒï¼ˆACNS0331ã€ACNS0332 å’Œ SJMB03ï¼‰çš„ 898 åæ‚£è€…çš„ä¸´åºŠã€åˆ†å­å’Œç”Ÿå­˜æ•°æ®ã€‚è¯¥é—¨æˆ·ç½‘ç«™å°†ä¸´åºŠæ•°æ®ä¸åŸºå› ç»„çªå˜å’Œ DNA ç”²åŸºåŒ–ç»„ç›¸ç»“åˆï¼Œèƒ½å¤Ÿå¯¹è‚¿ç˜¤äºšç»„å’Œç”Ÿå­˜ç»“æœè¿›è¡Œæ·±å…¥åˆ†æã€‚è¯¥é—¨æˆ·ç”± ProteinPaint æ¡†æ¶æä¾›æ”¯æŒçš„ç”¨æˆ·å‹å¥½å‹å¯è§†åŒ–å·¥å…·ä½¿è¿™äº›æ•°æ®çš„åŠ¨æ€æ¢ç´¢å’Œè‡ªå®šä¹‰åˆ†å±‚æˆä¸ºå¯èƒ½ï¼Œå…è®¸ç”¨æˆ·ä»å„ç§å˜é‡ä¸­è¿›è¡Œé€‰æ‹©æˆ–è‡ªå®šä¹‰è‡ªå·±çš„å˜é‡ã€‚é—¨æˆ·ä¸­çš„ Cox å›å½’åˆ†æå·¥å…·åœ¨æ£€æŸ¥å¼‚æ„æ•°æ®é›†ä¸­å˜é‡çš„é¢„åå½±å“æ–¹é¢è¡¨ç°å‡ºæ•ˆç”¨ã€‚æ­¤å¤–ï¼Œå¯¹æºå¸¦ KBTBD4 çªå˜çš„é«“æ¯ç»†èƒç˜¤åŠå…¶ç›¸åº”ç”²åŸºåŒ–ç»„çš„æ·±å…¥ç ”ç©¶äº§ç”Ÿäº†æœ‰åŠ©äºæ”¹è¿›åˆ†å­åˆ†ç±»çš„å…ˆå¯¼ã€‚è¿™äº›ç”¨ä¾‹å¼ºè°ƒäº†è¯¥é—¨æˆ·ç½‘ç«™åœ¨å¢å¼ºé£é™©åˆ†å±‚ã€ä¸ºé‡èº«å®šåˆ¶çš„æ²»ç–—ç­–ç•¥æä¾›ä¿¡æ¯ä»¥åŠæ­ç¤ºé«“æ¯ç»†èƒç˜¤æ‚£è€…åˆ†å­å¼‚è´¨æ€§<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1986188924621070336/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (1æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>ä¼˜é›…çš„ç½‘ç»œå¥—é¤</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šR package<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šHow to join this free online event with Salix Dubois, Tan Ho and Matthias GreniÃ©. Join us for our next Community Call, â€œGraceful Internet Packages,â€ featuring Matthias, Tan, and Salix. In this session, weâ€™ll explore how to design and maintain R packag... Continue reading: Graceful Internet Packages<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/graceful-internet-packages/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>DirectRMâ€”â€”åˆ©ç”¨ç›´æ¥RNAæµ‹åºæŠ€æœ¯å¯¹å¤šç§RNAä¿®é¥°è¿›è¡Œæ•´åˆæ£€æµ‹ï¼Œä»è€Œæ­ç¤ºå…¶é—´çš„ç›¸äº’ä½œç”¨å’Œç‰¹å¾ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immuneã€TMEã€cardiacã€kinaseã€TCGAã€sequencingã€RNAseqã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€R packageã€Seurat<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šRNA sequencing with DirectRM reveals how multiple RNA modifications interact within transcripts and molecules, offering a new way to explore the complexity of the...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/directrm-integrated-detection-of-landscape-and-crosstalk-between-multiple-rna-modifications-using-direct-rna-sequencing/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>ç ”ç©¶æ­ç¤ºï¼Œå‹åŠ›æ¿€ç´ é€šè¿‡æŸ“è‰²è´¨ç»“åˆçš„RNAæŠ‘åˆ¶å…³é”®è„‘åŸºå› çš„è¡¨è¾¾ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€TMEã€kinaseã€TCGAã€scRNAã€scDNAã€genomeã€Seuratã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šRNA sequencing reveals how stress hormones trigger chromatin silencing through lncRNAs that recruit PRC2, uncovering an epigenetic pathway linking stress signaling to altered neuronal gene expression...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/stress-hormones-silence-key-brain-genes-through-chromatin-bound-rnas-study-reveals/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>ä¸´åºŠNGSç§‘å­¦ä¸»ä»»</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscRNAã€scDNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šMemorial Sloan Kettering is hiring a Scientific Director of Clinical NGS to advance RNA sequencing and NGS-based cancer diagnostics, enabling precise tumor profiling, non-invasive testing, and personalized treatment strategies...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/scientific-director-of-clinical-ngs-2/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>TME</td>
<td>44</td>
</tr>
<tr>
<td>scRNA</td>
<td>41</td>
</tr>
<tr>
<td>genome</td>
<td>41</td>
</tr>
<tr>
<td>scDNA</td>
<td>34</td>
</tr>
<tr>
<td>scATAC</td>
<td>34</td>
</tr>
<tr>
<td>Seurat</td>
<td>30</td>
</tr>
<tr>
<td>cancer</td>
<td>28</td>
</tr>
<tr>
<td>glioma</td>
<td>28</td>
</tr>
<tr>
<td>TCGA</td>
<td>24</td>
</tr>
<tr>
<td>genomics</td>
<td>23</td>
</tr>
<tr>
<td>spatial</td>
<td>23</td>
</tr>
<tr>
<td>proteome</td>
<td>22</td>
</tr>
<tr>
<td>tumor</td>
<td>21</td>
</tr>
<tr>
<td>cardiac</td>
<td>21</td>
</tr>
<tr>
<td>histone</td>
<td>19</td>
</tr>
<tr>
<td>Scanpy</td>
<td>18</td>
</tr>
<tr>
<td>carcinoma</td>
<td>17</td>
</tr>
<tr>
<td>resistance</td>
<td>12</td>
</tr>
<tr>
<td>Hi-C</td>
<td>12</td>
</tr>
<tr>
<td>DepMap</td>
<td>12</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-å…¬ä¼—å·"></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (13æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247484012&amp;idx=1&amp;sn=5c59e1918da067d66af9bbff3ff813e4" target="_blank" rel="noopener noreferrer">è¯¦è§£ï¼šé…®ä½“ä»£è°¢</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503864&amp;idx=3&amp;sn=009cfa503cdfb0e641167246eebf8485" target="_blank" rel="noopener noreferrer">æœ€æ–°9.4åˆ†å•åŸºå› çº¯ç”Ÿä¿¡ï¼Œç»å…¸çš„æ€è·¯ä¸ºä½•èƒ½å‘è¡¨è¿™ä¹ˆé«˜åˆ†ï¼Œä½ è¡Œä½ ä¹Ÿä¸Šï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503864&amp;idx=2&amp;sn=27cd89a630ef708561956df398714ed4" target="_blank" rel="noopener noreferrer">è°è¯´å•åŸºå› æ²¡å‰é€”ï¼Œç»“åˆå•ç»†èƒï¼Œç©ºè½¬å’Œå®éªŒéªŒè¯ï¼Œç…§æ ·å‘8åˆ†1åŒºæ–‡ç« ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2NDcxMzYwNg==&amp;mid=2247490327&amp;idx=1&amp;sn=d471c2e56177e8f57861377dabbdb860" target="_blank" rel="noopener noreferrer">Science|å•ç»†èƒ2.0æ—¶ä»£æ¥äº†ï¼šPerturb-seqåœ¨ä½“åº”ç”¨é¦–ç§€ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzNzY2NDgyOQ==&amp;mid=2247493109&amp;idx=1&amp;sn=e31b38258a9a3606f9a5221af5528644" target="_blank" rel="noopener noreferrer">metasens åŒ…ç”¨äº metaåˆ†æä¸­çš„æ•æ„Ÿæ€§åˆ†æ:æé™Metaåˆ†æï¼ˆLimit meta-analysisï¼‰</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU0ODQyNjQxOA==&amp;mid=2247554767&amp;idx=1&amp;sn=db3c31dc17c1ac957c819d0c310ee341" target="_blank" rel="noopener noreferrer">Nature ï½œ â€œåŸºå› æ˜¾å¾®é•œâ€çµæ•åº¦æå‡ç™¾å€ï¼Œé¦–æ¬¡ç»˜åˆ¶å¥åº·äººç™Œç—‡çªå˜å…¨æ™¯å›¾</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821290&amp;idx=3&amp;sn=50ce5e953111c0121a42409b9c8feefb" target="_blank" rel="noopener noreferrer">Cellä¸¤ç¯‡20.6åˆ†å­åˆŠï¼šçœ‹è‚ é“èŒç¾¤åˆ†åˆ«å¦‚ä½•é€šè¿‡è›‹ç™½å’Œä»£è°¢ç‰©å‘æŒ¥ä¿ƒç™Œä½œç”¨ï¼Ÿ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247657180&amp;idx=3&amp;sn=938733197e4399064f7a8e2a167cc3d1" target="_blank" rel="noopener noreferrer">åŒæµå¤§å­¦é«˜äºšå¨/é«˜ç»è£/ç‹è¯‘è±å›¢é˜ŸCell Stem Cellï¼šæ­ç¤ºmâ¶Aä¿®é¥°é™åˆ¶äººç±»èƒšèƒå¹²ç»†èƒå…¨èƒ½æ€§çš„æœºåˆ¶</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656509004&amp;idx=3&amp;sn=ffbe2d88a9431c184ed32be07dcd8a3d" target="_blank" rel="noopener noreferrer">çªç ´è€è¯å›°å¢ƒï¼ä¸­å›½åŒ»å­¦ç§‘å­¦é™¢å¼€è¾Ÿé£Ÿç®¡é³ç™Œæ²»ç–—å…¨æ–°è·¯å¾„</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656509004&amp;idx=1&amp;sn=ac15b1e52f8319bb9d595787543dfb2b" target="_blank" rel="noopener noreferrer">è¶…è¶Šä¼ ç»Ÿåˆ†æœŸç³»ç»Ÿï¼æ–°æ–¹æ³•æ˜¾ç€æå‡éå°ç»†èƒè‚ºç™Œé£é™©åˆ†å±‚å‡†ç¡®æ€§ï¼Œç ´è§£è‚¿ç˜¤å¾®ç¯å¢ƒç»†èƒç©ºé—´æ’åˆ—å¯†ç </a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649496&amp;idx=5&amp;sn=6d64ab8be4e3d1a23fa3f2ae194ddde7" target="_blank" rel="noopener noreferrer">IF 29 | æ¸…åå¤§å­¦/å±±ä¸œå¤§å­¦åˆä½œæ­ç¤ºè°ƒæ§äººç±»èƒšèƒåŸºå› ç»„æ¿€æ´»å’Œæ—©æœŸå‘è‚²æ–°é¶ç‚¹</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649496&amp;idx=2&amp;sn=6d73470235d5f0eb0ff9928e523f337d" target="_blank" rel="noopener noreferrer">è‚¿ç˜¤è®ºæ–‡æŠ•ç¨¿ä¸‰å¤§éšå½¢é£é™©ä¸åˆè§„çº¢çº¿ï¼Œé¡¶åˆŠå‰¯ä¸»ç¼–æ‰‹æŠŠæ‰‹æ•™ä½ é¿å‘</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkxOTI0Mjc3Mw==&amp;mid=2247496498&amp;idx=1&amp;sn=b4b09bfa70b0523ccd3522945210b497" target="_blank" rel="noopener noreferrer">è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒ(TAMs)ç®€è¦æ¦‚è¿°</a></li>
</ul>
</div>
</details>

<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (34æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217432" target="_blank" rel="noopener noreferrer">GSE217432 å¯¹åˆ†æ³Œè„‚è‚ªé…¸çš„è§£è„‚è€¶æ°é…µæ¯èŒçš„æ¯”è¾ƒè½¬å½•ç»„å­¦åˆ†ææ­ç¤ºäº†ç»†èƒå£è›‹ç™½çš„é‡è¦æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274063" target="_blank" rel="noopener noreferrer">GSE274063 é‰´å®šæ–‘é©¬é±¼ä¸­æ§åˆ¶å†…èƒšå±‚å½¢æˆå’Œå·¦å³æ¨¡å¼çš„é‡å¤SOXå› å­åŠŸèƒ½åˆ†åŒ–çš„åˆ†å­åŸºç¡€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268442" target="_blank" rel="noopener noreferrer">GSE268442 ç¼ºè¡€æ€§å’ä¸­å¤§é¼ åŠ¨è„‰å†…ç§»æ¤äººç¥ç»å¹²ç»†èƒåç»†èƒå¤–å›Šæ³¡è½¬å½•ç»„ï¼ˆmicroRNAï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303861" target="_blank" rel="noopener noreferrer">GSE303861 ç”Ÿé•¿å› å­FGF21é€šè¿‡ç»„è›‹ç™½å»ä¹™é…°åŒ–é…¶HDAC4ç»´æŒå»ç¥ç»æ”¯é…å¼•èµ·çš„éª¨éª¼è‚Œèç¼©ä¸­çš„ç¥ç»è‚Œè‚‰æ¥å¤´</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302582" target="_blank" rel="noopener noreferrer">GSE302582 çŸ­è·‘é—´æ­‡è®­ç»ƒé©±åŠ¨äººç±»ç‹¬ç‰¹çš„çº¿ç²’ä½“åº”æ¿€ååº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309046" target="_blank" rel="noopener noreferrer">GSE309046 ä½“å†…æŠ—FAP CAR-Tç–—æ³•å¯å‡å°‘ä»£è°¢åŠŸèƒ½éšœç¢ç›¸å…³æ€§è„‚è‚ªæ€§è‚ç‚ä¸­çš„çº¤ç»´åŒ–å¹¶æ¢å¤è‚è„ç¨³æ€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274809" target="_blank" rel="noopener noreferrer">GSE274809 ä½ caspase 8 è¡¨è¾¾ä¿ƒè¿›ç¥ç»å…ƒç¥–ç»†èƒæ‹Ÿæ€å’Œå°ç»†èƒè‚ºç™Œè½¬ç§»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274232" target="_blank" rel="noopener noreferrer">GSE274232 ä½ caspase 8 è¡¨è¾¾ä¿ƒè¿›ç¥ç»å…ƒç¥–ç»†èƒæ‹Ÿæ€å’Œå°ç»†èƒè‚ºç™Œè½¬ç§»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306775" target="_blank" rel="noopener noreferrer">GSE306775 åœ¨ HAP1 MTHFD1-K56R ç»†èƒä¸­è¿›è¡Œå…¨åŸºå› ç»„ CRISPR æ•²é™¤ç­›é€‰ï¼Œä»¥é‰´å®šèµ‹äºˆæŠ—è…ºè‹·æ¯’æ€§çš„åŸºå› </a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299897" target="_blank" rel="noopener noreferrer">GSE299897 GW9662ï¼Œä¸€ç§è¿‡æ°§åŒ–ç‰©é…¶ä½“å¢æ®–æ¿€æ´»å—ä½“Î³ (PPARÎ³) æŠ‘åˆ¶å‰‚ï¼Œä¼šæŸå®³æ–‘é©¬é±¼çš„æ—©æœŸèƒšèƒå‘è‚²ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281261" target="_blank" rel="noopener noreferrer">GSE281261 é’¨è¢«ä¸€ç§ä¼˜åŠ¿äººç±»è‚ é“å¾®ç”Ÿç‰©â€”â€”é»æ¶²çœŸæ†èŒï¼ˆEubacterium limosumï¼‰ç”¨äºä¹³é…¸æ¶ˆè€—å’ŒçŸ­é“¾è„‚è‚ªé…¸ï¼ˆSCFAï¼‰ç”Ÿæˆã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305038" target="_blank" rel="noopener noreferrer">GSE305038 å•æ—¥æ´»åŠ¨é‡å‡å°‘ä¼šæ”¹å˜æ¬¡æ—¥çš„è½¬å½•ç»„å’Œä»£è°¢è¿åŠ¨ååº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281233" target="_blank" rel="noopener noreferrer">GSE281233 GPC2-CAR T ç»†èƒå¯¹åŸä½é«“æ¯ç»†èƒç˜¤å¼‚ç§ç§»æ¤å…·æœ‰å¼ºå¤§çš„ä¸´åºŠå‰æ´»æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287760" target="_blank" rel="noopener noreferrer">GSE287760 é›„æ¿€ç´ å—ä½“é©±åŠ¨å¤šèƒºåˆæˆï¼Œä»è€Œå¢åŠ æ‚£å‰åˆ—è…ºç™Œçš„é£é™©</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE240493" target="_blank" rel="noopener noreferrer">GSE240493 é‡å¤è¡Œä¸ºæµ‹è¯•å’Œæ±‡æ€»æŒ‡æ ‡çš„ä½¿ç”¨æ­ç¤ºäº†ä¸´åºŠå‰å•®é½¿åŠ¨ç‰©æ¨¡å‹ä¸­çš„ç‰¹è´¨ç„¦è™‘</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308047" target="_blank" rel="noopener noreferrer">GSE308047 å‡è¡€é…¶åˆºæ¿€çš„è‚æ˜ŸçŠ¶ç»†èƒä¸­æ–°å‹åŸºå› è¡¨è¾¾ç¨‹åºçš„é‰´å®š</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE245166" target="_blank" rel="noopener noreferrer">GSE245166 æ‹Ÿå—èŠ¥é˜³ç¦»å­æ°¨åŸºé…¸è½¬è¿è›‹ç™½ (CAT) æ˜¯ä¸€ç§å¯¹å†…å¸æ€§é™¤è‰å‰‚ L-è†¦ä¸èŒç´ å…·æœ‰é«˜äº²å’ŒåŠ›çš„è½¬è¿è›‹ç™½</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302398" target="_blank" rel="noopener noreferrer">GSE302398 æ­ç¤ºPPARÎ³å’Œå…ç–«è›‹ç™½é…¶ä½“åœ¨ILC2è°ƒæ§ä¸­çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296941" target="_blank" rel="noopener noreferrer">GSE296941 è±èŒµè¡£è—»â€œé‡ç”Ÿå‹â€èŒæ ªåŸºç¡€è½¬å½•ç»„çš„å·®å¼‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270329" target="_blank" rel="noopener noreferrer">GSE270329 AINTEGUMENTA ç£·é…¸åŒ–å¼€å…³æ§åˆ¶æ¬¡çº§ç”Ÿé•¿è¿‡ç¨‹ä¸­åŒä¾§å¹²ç»†èƒçš„æ´»æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303964" target="_blank" rel="noopener noreferrer">GSE303964 ä¸æ°¨é…¸ tRNA ç«äº‰è°ƒæ§ä¸æ°¨é…¸æ•æ„Ÿå¯†ç å­çš„ mRNA ç¿»è¯‘</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE237016" target="_blank" rel="noopener noreferrer">GSE237016 APOBEC3 é€šè¿‡ IL1A/AP-1 ä¿¡å·é€šè·¯ä¿ƒè¿›é³çŠ¶ç»†èƒåˆ†åŒ–å’Œè½¬ç§»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271260" target="_blank" rel="noopener noreferrer">GSE271260 ç¥ç»å…ƒå‰ä½“ç»†èƒæ‹Ÿæ€é©±åŠ¨å°ç»†èƒè‚ºç™Œè½¬ç§»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307666" target="_blank" rel="noopener noreferrer">GSE307666 eIF3d å’Œ eIF3e ä»‹å¯¼å¯¹ç¼ºæ°§çš„é€‰æ‹©æ€§ç¿»è¯‘è°ƒæ§ï¼Œè¿™ç§è°ƒæ§å¯è¢«å°åˆ†å­æŠ‘åˆ¶ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE169493" target="_blank" rel="noopener noreferrer">GSE169493 å½±å“çƒ­å¸¦çº¸èœ‚ï¼ˆPolistes canadensisï¼‰æˆè™«è¡Œä¸ºå˜å¼‚çš„å› ç´ </a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294234" target="_blank" rel="noopener noreferrer">GSE294234 äººç±»æ­»åç»„ç»‡æ ·æœ¬çš„å…¨åŸºå› ç»„ç”²åŸºåŒ–è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE213241" target="_blank" rel="noopener noreferrer">GSE213241 VHLçªå˜ç»†èƒçš„é—ä¼ æ˜“æ„Ÿæ€§ç ”ç©¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288481" target="_blank" rel="noopener noreferrer">å°é¼ è‚ é“ Pdgfra+ ç»†èƒçš„ GSE288481 å•ç»†èƒ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280922" target="_blank" rel="noopener noreferrer">GSE280922 åšæ¥éœ‰ç´ æŸä¼¤å°é¼ è‚ºçš„å•ç»†èƒRNAæµ‹åºåˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306269" target="_blank" rel="noopener noreferrer">GSE306269 èŒæ ªå¾ˆé‡è¦ï¼šå®¿ä¸»ååº”åæ˜ äº†é±¿é±¼-å¼§èŒå…±ç”Ÿä½“ä¸­çš„å…±ç”Ÿä½“èµ·æº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281841" target="_blank" rel="noopener noreferrer">GSE281841 å¤–å‘¨åŠ¨è„‰ç–¾ç—…ç‹­çª„1çº§ä¸4çº§å’Œ5çº§æ‚£è€…çš„åŸºå› è¡¨è¾¾æ•°æ®</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250516" target="_blank" rel="noopener noreferrer">GSE250516 IAF scRNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250515" target="_blank" rel="noopener noreferrer">GSE250515 GLIS3 RNA-seq</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250514" target="_blank" rel="noopener noreferrer">GSE250514 GLIS3 ChIP-seq</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-06 21:41</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>